Pyridoxal phosphate site in glycogen phosphorylase b: structure in native enzyme and in three derivatives with modified cofactors. 1987

N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
Laboratory of Molecular Biophysics, University of Oxford, U.K.

The detailed environment of the essential cofactor pyridoxal 5'-phosphate in glycogen phosphorylase b, resulting from crystallographic refinement at 1.9-A resolution, is described. The pyridoxal ring is buried in a nonpolar site containing three aromatic rings while the 5'-phosphate group is highly solvated and makes only three direct contacts to the protein. The pyridine nitrogen interacts via a water with protein atoms [main chain carbonyl oxygen (Asn-133) and OH of tyrosine (Tyr-90)]. The crystal structures of three active derivatives of phosphorylase reconstituted with 5'-deoxypyridoxal 5'-methylenephosphonate (PDMP), 6-fluoropyridoxal 5'-phosphate (6-FPLP), and pyridoxal (PL) in place of the natural cofactor have been determined at 2.5-A resolution. The results for PDMP-phosphorylase show a closer proximity of the phosphonate group to the NZ atom of a lysine (Lys-574) than that observed in the native enzyme, consistent with 31P NMR studies that have shown a change in ionization state of the phosphonate group compared to the native cofactor phosphate. The replacement of the polar 5'-ester linkage by a CH2 group results in a small shift of a water and its hydrogen-bonded tyrosine (Tyr-648). In 6-FPLP-phosphorylase the fluorine is accommodated with no significant change in structure. It is suggested that substitution of the electronegative fluorine at the 6-position may result in lower activity of 6-FPLP-phosphorylase through a strengthening of hydrogen-bonded interactions to the pyridine nitrogen N1.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010763 Phosphorylase b The inactive form of GLYCOGEN PHOSPHORYLASE that is converted to the active form PHOSPHORYLASE A via phosphorylation by PHOSPHORYLASE KINASE and ATP.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011732 Pyridoxal Phosphate This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE). Pyridoxal 5-Phosphate,Pyridoxal-P,Phosphate, Pyridoxal,Pyridoxal 5 Phosphate,Pyridoxal P
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D006005 Phosphorylases A class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals (GLYCOGEN PHOSPHORYLASE) and in plants (STARCH PHOSPHORYLASE). Glucan Phosphorylase,Phosphorylase,alpha-Glucan Phosphorylases

Related Publications

N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
June 1976, European journal of biochemistry,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
December 1978, Biochemistry,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
May 1978, Biochemical and biophysical research communications,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
July 1983, European journal of biochemistry,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
January 1984, Progress in clinical and biological research,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
May 1972, Biochemistry,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
November 1977, Proceedings of the National Academy of Sciences of the United States of America,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
April 1978, Biochemistry,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
January 1973, FEBS letters,
N G Oikonomakos, and L N Johnson, and K R Acharya, and D I Stuart, and D Barford, and J Hajdu, and K M Varvill, and A E Melpidou, and T Papageorgiou, and D J Graves
July 1975, FEBS letters,
Copied contents to your clipboard!